Cargando…

Anti-VEGF Cancer Therapy in Nephrology Practice

Expanded clinical experience with the antivascular endothelial growth factor (VEGF) agents has come with increasing recognition of their renal adverse effects. Although renal histology is rarely sought in antiangiogenic-treated cancer patients, kidney damage related to anti-VEGF is now established....

Descripción completa

Detalles Bibliográficos
Autor principal: Izzedine, Hassan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4158308/
https://www.ncbi.nlm.nih.gov/pubmed/25210627
http://dx.doi.org/10.1155/2014/143426